Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.

JCO precision oncology·2026
Same author

Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].

Gynecologic oncology·2026
Same author

The stentless temptation: drug-coated balloons between evidence, enthusiasm, and historical caution.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Study outcome and journal impact factor: a meta-epidemiologic analysis of phase III gynecologic oncology trials.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Innovation through standardization: Reducing the ileostomy rates while targeting zero anastomotic leaks at cytoreductive surgery.

Gynecologic oncology·2026
Same author

Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Related Experiment Video

Updated: May 5, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.2K

The new 2023 endometrial cancer FIGO staging system: balancing innovation with complexity.

Emilia Palmieri1, Andrea Mariani2, Robert Coleman3

  • 1Mayo Clinic, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Rochester, MN, USA; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Department of Women, Children and Public Health Sciences, Gynecologic Oncology Unit, Roma, Italy.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|May 15, 2025
PubMed
Summary
This summary is machine-generated.

The International Federation of Gynecology and Obstetrics updated endometrial cancer staging to include molecular and histopathologic features for personalized medicine. Challenges include global testing availability and validation needs for this new system.

Keywords:
Endometrial NeoplasmsGynecologic NeoplasmsUterine Neoplasms

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.1K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.8K

Related Experiment Videos

Last Updated: May 5, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.2K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.1K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.8K

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Precision Medicine

Background:

  • The International Federation of Gynecology and Obstetrics (FIGO) introduced a new endometrial cancer staging system in August 2023.
  • This system integrates histopathologic and molecular tumor characteristics with anatomic extent.
  • The goal is to enhance prognostication and identify treatment-relevant patient groups through personalized medicine.

Purpose of the Study:

  • To discuss the implications and challenges of the updated FIGO staging system for endometrial cancer.
  • To explore the integration of histopathologic and molecular features in cancer staging.
  • To address the need for standardization and prospective validation of new parameters.

Main Methods:

  • A meeting of gynecologic oncologists and pathologists was convened to discuss the staging system.
  • The article summarizes reflections on key elements like histopathologic features and molecular classification.
  • Discussions focused on the fundamental purpose of staging: prognostication and treatment guidance versus common language.

Main Results:

  • The new FIGO staging system represents a significant advancement toward personalized medicine in endometrial cancer.
  • Implementation challenges include heterogeneous molecular testing availability and the need for validation of histopathological parameters.
  • Key areas for future research include collaborative efforts and prospective studies to generate robust evidence.

Conclusions:

  • The updated FIGO staging system aims to improve patient stratification and treatment decisions.
  • Further research and standardization are crucial for global applicability and effectiveness.
  • Refinement of the system will advance precision medicine in endometrial cancer care.